Sign inGet started

See Tai Sandi

Insider CIK 2009350 · LXEO Chief Development Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LXEO Lexeo Therapeutics, Inc. S Sale2025-11-182025-11-20386$9.27 $3.6K65,476SEC↗
LXEO Lexeo Therapeutics, Inc. S Sale2025-10-172025-10-173,844$8.94 $34.4K65,906SEC↗
LXEO Lexeo Therapeutics, Inc. S Sale2025-10-172025-10-1744$9.56 $42165,862SEC↗
LXEO Lexeo Therapeutics, Inc. A Award2025-10-152025-10-1710,890— $069,750SEC↗
LXEO Lexeo Therapeutics, Inc. S Sale2025-08-182025-08-20382$4.67 $1.8K58,860SEC↗
LXEO Lexeo Therapeutics, Inc. S Sale2025-05-162025-05-20367$2.77 $1.0K59,242SEC↗
LXEO Lexeo Therapeutics, Inc. A Award2025-03-142025-04-095,720$2.61 $14.9K59,609SEC↗
LXEO Lexeo Therapeutics, Inc. S Sale2025-02-192025-02-211,486$4.41 $6.6K53,889SEC↗
LXEO Lexeo Therapeutics, Inc. A Award deriv2025-01-072025-01-1077,500— $077,500SEC↗
LXEO Lexeo Therapeutics, Inc. A Award2025-01-072025-01-1038,750— $055,375SEC↗